The natural progression of peanut allergy: Resolution and the possibility of recurrence David M. Fleischer, MDa, Mary Kay Conover-Walker, MSN, RN, CRNPa, Lynn Christie, MS, RD, LDb, A.Wesley Burks, MDb, Robert A. Wood, MDa Journal of Allergy and Clinical Immunology Volume 112, Issue 1, Pages 183-189 (July 2003) DOI: 10.1067/mai.2003.1517 Copyright © 2003 Mosby, Inc. Terms and Conditions
Fig. 1 PN-IgE levels at challenge in patients who passed challenges (n = 44; range, < 0.35 to 4.9 kUA/L; median, < 0.35 kUA/L) and failed challenges (n = 36; range, < 0.35 to 5 kUA/L; median, 1.85 kUA/L). Journal of Allergy and Clinical Immunology 2003 112, 183-189DOI: (10.1067/mai.2003.1517) Copyright © 2003 Mosby, Inc. Terms and Conditions
Fig. 2 Initial PN-IgE levels at diagnosis in patients who passed challenges (n = 21; range, < 0.35 to 82.2 kUA/L; median, 1.1 kUA/L) and failed challenges (n = 13; range, < 0.35 to 23.9 kUA/L; median, 3.0 kUA/L). Journal of Allergy and Clinical Immunology 2003 112, 183-189DOI: (10.1067/mai.2003.1517) Copyright © 2003 Mosby, Inc. Terms and Conditions